Two compounds progress to phase 1 trials, offering hope for new cancer drugs
The Innovative Medicines Initiative’s European Lead Factory has helped identify two drug candidates for cancer treatment that have now progressed to clinical testing.
'Google Maps' for tumours can pinpoint which tumour region should be studied - at unprecedented speed
Researchers from IMI project IMMUCAN are using extensive imaging data and statistical analysis to produce detailed descriptions of tumours to figure out which regions should be investigated further.
New method matches drugs with faulty DNA replication, helping identify childhood cancer drug candidates
The IMI-funded ITCC-P4 project’s methodology helped identify some of the best targets in childhood tumours that could be candidates for treatment with adult therapies.
Europe’s top childhood cancer experts lay ground rules for moving forward on drug testing
The ITCCP4 team also joined forces with US experts in paediatric cancer to reach a much-needed consensus on the best way forward for testing of childhood cancer drugs.
Blood cancer: 63k patient datasets readied to reveal ‘untapped’ potential of AI in cancer research
IMI’s HARMONY Alliance is using advanced data analysis methods based on artificial intelligence and machine learning to answer questions about haematological malignancies.
Notorious superbug found to be a hidden disease outside hospital settings
Researchers from IMI project COMBACTE-CDI filled important knowledge gaps on the scale of C. diff infections, and sequenced the genomes of hundreds of strains for future researchers.
